Blog - INTERNET MÉDICA

Inibidores a Fosfodiesterase Tipo 5 (Phosphodiesterase 5 (PDE-5) Inhibitors 2024)

Por Paulo Leite 06/02/2024

■ The efficacy of PDE5 inhibitors in diabetic patients

Agnieszka Swiecicka

Andrology. 2023 Feb; 11(2): 245–256

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107754/

■ Phosdiesterase 5 (PDE-5 inhibitors (sildenafil, tadalafil, and vardenafil) effects on esophageal motility: a systematic review

A Shafiee, R A Bahri, M M Teymouri et al

BMC Gastroenterol 2023, vol 23: 170

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201782/

■ Exploring the multifaceted potential of sildenafil in Medicine

Ciprian Pușcașu, Anca Zanfirescu, Simona Negreș, Oana Cristina Șeremet

Medicina (Kaunas) 2023 Dec; 59(12): 2190

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10744870/

■ Sildenafil and kidney function in heart failure with preserved ejection fraction

Daniel Edmonston, Matthew Sparks, Sudarshan Rajagopal, Myles Wolf

Kidney360. 2023 May; 4(5): 631–640

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278830/

■ Advancement in phosphodiesterase 5 inhibitors: unveiling presente and future perspectives

Ahmed K. ElHady, Dalia S. El-Gamil, Mohammad Abdel-Halim, Ashraf H. Abadi

Pharmaceuticals (Basel) 2023 Sep; 16(9): 1266

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536424/

■ Predictors of the response to phosphodiesterase-5 inhibitors in pulonary arterial hypertension: an analysis of the Spanish registry

Agustin R. Garcia, Isabel Blanco, Lluis Ramon, et al

Respir Res. 2023; 24: 223

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503122/

■ Unmasking hidden risks: the surprising link between PDE5 inhibitors and seizure susceptibility

Alex Luiz Menezes da Silva, Chirlene Pinheiro Nascimento, Julianne Elba Cunha Azevedo et al

PLoS One. 2023; 18(11): e0294754.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688920/

■ Treating diabetes with combination of phosphodiesterase 5 inhibitos and hydroxychloroquine – a possible prevention strategy for COVID-19?

Rakesh C. Kukreja, Rui Wang, Saisudha Koka, Anindita Das, Arun Samidurai, Lei Xi

Mol Cell Biochem. 2023; 478(3): 679–696

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421626/

■ Risk of ocular adverse events associated with use of phosphodiesterase 5 inhibitors in men in the US

Mahyar Etminan, Mohit Sodhi, Frederick S. Mikelberg, David Maberley

JAMA Ophthalmol. 2022 May; 140(5): 480–484.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990352/

■ Outcomes with phosphodiesterase-5 inhibitors use after lefet ventricular assist device: A STS-INTERMACS Analysis

Wilson Grandin, Gaurav Gulati, Jose I Nunez, Kevin Kennedy, et al

Circ Heart Fail. 2022 Apr; 15(4): e008613

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205418/

■ Assessment of combination therapies vs monotherapy for erectile dysfunction

I Mykoniatis, N Pyrgidis, I Sokolakis et al

JAMA Netw Open 2021, vol 4 (2): e2036337

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893498/

■ Phosphodiesterase-5 inhibitors and the heart: compound cardioportection?

D C Hutching, S G Anderson, J L Caldwell, A W Trafford

Heart 2018, vol 104 (issue 15)

https://heart.bmj.com/content/104/15/1244

■ Acesso gratuito

■ Um dos Blog de Medicina mais acessado em todo o mundo. Mais de 1250 temas médicos já disponíveis online

■ Use o mecanismo de busca – PESQUISAR na home page.

■ Acesse ARQUIVO e encontre os temas incluídos no Blog a cada mês, desde maio 2017

■ Blog Internet Médica – www.internetmedica.com.br

■ Médico Responsável: Dr Paulo Fernando Leite

CRMMG: 7026

Consultório (Novo Endereço): Rua Rio Grande do Norte 23/ 9 andar

Tels 996346835 32438504

Belo Horizonte/MG/Brasil

Email: pfleite1873@gmail.com

Fevereiro 2024

Oncologia: Como Eu Trato (Oncology: How I Treat)

Por Paulo Leite 03/02/2024

Oncologia: Como Eu Trato (Oncology: How I Treat)

■ How I treat endocrine-dependent metastatic breast cancer

Gombos, A. Goncalves, G. Curigliano, R. Bartsch et al

ESMO Open. 2023 Apr; 8(2): 100882

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969253/

■ How we treat esophagela squamous cell carcinoma

H.C. Puhr, G.W. Prager, A. Ilhan-Mutlu

ESMO Open. 2023 Feb; 8(1): 100789

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958251/

■ How I treat diffuse large B-cell lymphoma

Melchardt, A. Egle, R. Greil

ESMO Open. 2023 Feb; 8(1): 100750

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843196/

■ How I treat multiple myeloma in geriatric patients

T Facon, X Leleu, S Manier

Blood 2024, vol 143 (3): 224-232

https://ashpublications.org/blood/article/143/3/224/494221/How-I-treat-multiple-myeloma-in-geriatric-patients

■ How I treat secondary CNS involvement by agressive lymphomas

J P Alderuccio, L Nayak, K Cwyarski

https://ashpublications.org/blood/article-abstract/142/21/1771/497854/How-I-treat-secondary-CNS-involvement-by?redirectedFrom=fulltext